Volume 62, Issue 1, Pages (July 2002)

Slides:

Advertisements

Similar presentations

Kamyar Kalantar-Zadeh Kidney International

Advertisements

Vitamin D levels and patient outcome in chronic kidney disease

Volume 68, Issue 3, Pages (September 2005)

Volume 70, Issue 4, Pages (August 2006)

Volume 54, Issue 2, Pages (August 1998)

Long-term evolution of cardiomyopathy in dialysis patients

Beta blockers in the management of chronic kidney disease

Cardiac Remodeling in Obesity

The overdriven glomerulus as a cardiovascular risk factor

Linear and logistic regression analysis

Confounding: What it is and how to deal with it

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

C-reactive protein and dialysis access

C-reactive protein and dialysis access

The overdriven glomerulus as a cardiovascular risk factor

Volume 54, Issue 2, Pages (August 1998)

Kamyar Kalantar-Zadeh Kidney International

Homocysteine and risk in end-stage renal disease: a matter of context

George A. Kaysen, Burl R. Don

Volume 67, Issue 6, Pages (June 2005)

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment Martina Franz, Wolfgang Woloszczuk, Walter.

Body weight is a fluctuating parameter in hemodialysis patients

G. Tripepi, K.J. Jager, F.W. Dekker, C. Wanner, C. Zoccali

Erythropoietin and progression of CKD

Body size and outcomes on peritoneal dialysis in the United States

Volume 59, Issue 4, Pages (April 2001)

Blood pressure targets in hemodialysis patients

Volume 56, Issue 4, Pages (October 1999)

Vitamin D levels and patient outcome in chronic kidney disease

Effects of hemodialysis on cardiac function

Volume 61, Issue 6, Pages (June 2002)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier

Alternate-day dialysis may be needed for hemodialysis patients

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

Volume 71, Issue 6, Pages (March 2007)

Long-term evolution of cardiomyopathy in dialysis patients

Volume 53, Issue 4, Pages (April 1998)

Electrocardiographic abnormalities and uremic cardiomyopathy

Terry Behrend, Steven B. Miller, M.D Kidney International

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related.

Volume 70, Issue 6, Pages (September 2006)

Volume 87, Issue 5, Pages (May 2015)

Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors Carmine Zoccali, Francesca Mallamaci,

Volume 70, Issue 3, Pages (August 2006)

Volume 72, Issue 5, Pages (November 1977)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

The valuable contribution of observational studies to nephrology

Carmine Zoccali, Francesca Mallamaci Kidney International

Current status of maintenance hemodialysis in Beijing, China

Low triiodothyronine and survival in end-stage renal disease

Volume 61, Issue 2, Pages (February 2002)

Volume 80, Issue 10, Pages (November 2011)

Volume 80, Issue 10, Pages (November 2011)

Volume 60, Issue 6, Pages (December 2001)

Volume 68, Issue 5, Pages (November 2005)

Charles A. Herzog Kidney International

Pathophysiology of cardiovascular disease in hemodialysis patients

The Additional Prognostic Value of Left Atrial Volume on the Outcome of Patients After Surgical Ventricular Reconstruction Serenella Castelvecchio, MD,

Volume 68, Issue 2, Pages (August 2005)

Volume 64, Issue 6, Pages (December 2003)

Volume 58, Issue 1, Pages (July 2000)

Volume 66, Issue 2, Pages (August 2004)

James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon

Volume 68, Issue 3, Pages (September 2005)

Volume 77, Issue 12, Pages (June 2010)

Diagnostic methods 2: receiver operating characteristic (ROC) curves

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Unadjusted means according to normal versus abnormal cardiac variables among current smokers. DD, diastolic dysfunction; LVM, left ventricular mass; RVFAC,

Presentation transcript:

Volume 62, Issue 1, Pages 339-345 (July 2002) Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients Carmine Zoccali, Francesca Mallamaci, Renke Maas, Francesco A. Benedetto, Giovanni Tripepi, Lorenzo S. Malatino, Alessandro Cataliotti, Ignazio Bellanuova, Rainer Böger, on behalf of The Creed Investigators Kidney International Volume 62, Issue 1, Pages 339-345 (July 2002) DOI: 10.1046/j.1523-1755.2002.00437.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Relationships between plasma asymmetric dimethylarginine (ADMA) and mean wall thickness (MWT; A), relative wall thickness (RWT; B), left ventricular mass index (LVMI; C) and left ventricular ejection fraction (D). Kidney International 2002 62, 339-345DOI: (10.1046/j.1523-1755.2002.00437.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Relationship between plasma ADMA and geometric pattern of the left ventricle. Data are median and inter-quartile range. *P < 0.001 vs. patients with eccentric hypertrophy or with normal LVM Kidney International 2002 62, 339-345DOI: (10.1046/j.1523-1755.2002.00437.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Receiver operating characteristic (ROC) curves for plasma ADMA concentration in predicting concentric left ventricular hypertrophy (see Methods section; area, 0.73; 95% CI, 0.66 to 0.80; P < 0.001). Kidney International 2002 62, 339-345DOI: (10.1046/j.1523-1755.2002.00437.x) Copyright © 2002 International Society of Nephrology Terms and Conditions